2022
DOI: 10.1111/jdv.18749
|View full text |Cite
|
Sign up to set email alerts
|

Schimmelpenning–Feuerstein–Mims syndrome: A case series and brief literature review of genetically ascertained cases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 10 publications
(8 reference statements)
0
0
0
Order By: Relevance
“…Importantly, the earlier in embryogenesis they occur, the more widespread the nevus and the greater the chance (and more extensive and severe) of extracutaneous anomalies. Among patients diagnosed with NSS (which we consider identical to LNSS), HRAS mutations were the most common, including G13R [34,35,[48][49][50][51], G12C [25], G12S [26], and G13V [23], as were KRAS mutations, specifically G12D [14,22,24,25,26,27,30], G12V [28], G12C [20,53], and A146T [31]. One NRAS mutation (Q61R) was found, marking the first causative NRAS mutation in NSS [5], as well as unique mutations such as in the PRKRIR gene (A1674T, R558S) for one patient, and a mutation in the RRP7A gene (C670T, R224W) in another [27].…”
Section: /6 Mutational Analysismentioning
confidence: 99%
“…Importantly, the earlier in embryogenesis they occur, the more widespread the nevus and the greater the chance (and more extensive and severe) of extracutaneous anomalies. Among patients diagnosed with NSS (which we consider identical to LNSS), HRAS mutations were the most common, including G13R [34,35,[48][49][50][51], G12C [25], G12S [26], and G13V [23], as were KRAS mutations, specifically G12D [14,22,24,25,26,27,30], G12V [28], G12C [20,53], and A146T [31]. One NRAS mutation (Q61R) was found, marking the first causative NRAS mutation in NSS [5], as well as unique mutations such as in the PRKRIR gene (A1674T, R558S) for one patient, and a mutation in the RRP7A gene (C670T, R224W) in another [27].…”
Section: /6 Mutational Analysismentioning
confidence: 99%